Onconova Therapeutics, Inc. (96)
Browse by Contract Category
Contracts
-
Onconova Therapeutics, Inc. 2021 Incentive Compensation Plan, as Amended and Restated, as approved by stockholders
(Filed With SEC on November 14, 2022)
-
Employment Agreement Amendment between Onconova Therapeutics, Inc. and Mark Guerin dated June 10, 2022
(Filed With SEC on June 13, 2022)
-
Form of Non-Qualified Stock Option Agreement
(Filed With SEC on November 15, 2021)
-
Form of Restricted Stock Unit Agreement
(Filed With SEC on November 15, 2021)
-
Underwriting Agreement, dated September 23, 2021, by and between Onconova Therapeutics, Inc. and Guggenheim Securities, LLC
(Filed With SEC on September 24, 2021)
-
Equity Distribution Agreement, dated as of August 20, 2021, between Onconova Therapeutics, Inc. and Piper Sandler & Co
(Filed With SEC on August 20, 2021)
-
Employment Agreement, dated March 9, 2021, by and between Onconova Therapeutics, Inc. and Abraham N. Oler
(Filed With SEC on August 16, 2021)
-
Employment Agreement, dated June 14, 2021, by and between Onconova Therapeutics, Inc. and Mark Stephen Gelder,M.D
(Filed With SEC on August 16, 2021)
-
Amendment to Employment Agreement, dated as of March 18, 2021, by and between Onconova Therapeutics, Inc. and Steven M. Fruchtman, M.D
(Filed With SEC on March 18, 2021)
-
Underwriting Agreement, dated February 10, 2021, by and between Onconova Therapeutics, Inc. and Guggenheim Securities, LLC
(Filed With SEC on February 12, 2021)
-
Form of Purchase Agreement, dated as of January 7, 2021, by and among Onconova Therapeutics, Inc. and the investors party thereto
(Filed With SEC on January 8, 2021)
-
Form of Stock Appreciation Right Award Agreement (for Non-Employee Directors)
(Filed With SEC on November 16, 2020)
-
Form of Stock Appreciation Right Award Agreement
(Filed With SEC on July 10, 2020)
-
Form of Performance Stock Unit Award Agreement
(Filed With SEC on July 10, 2020)
-
Description of the Company's Securities Registered under Section 12 of the Securities Exchange Act of 1934, as amended
(Filed With SEC on March 27, 2020)
-
Form of Securities Purchase Agreement, dated as of December 31, 2019, among Onconova Therapeutics, Inc. and the Purchasers named therein
(Filed With SEC on January 3, 2020)
-
Form of Placement Agent Warrant
(Filed With SEC on January 3, 2020)
-
Distribution, License and Supply Agreement, dated as of December 18, 2019, by and between Onconova Therapeutics, Inc. and Specialised Therapeutics Asia Pte. Ltd
(Filed With SEC on December 19, 2019)
-
Form of Investor Warrant
(Filed With SEC on December 19, 2019)
-
Form of Placement Agent Warrant
(Filed With SEC on December 19, 2019)
-
Form of Securities Purchase Agreement, dated as of December 17, 2019, among Onconova Therapeutics, Inc. and the Purchasers named therein
(Filed With SEC on December 19, 2019)
-
Form of Securities Purchase Agreement, dated as of December 6, 2019, among Onconova Therapeutics, Inc. and the Purchasers named therein
(Filed With SEC on December 10, 2019)
-
Form of Placement Agent Warrant
(Filed With SEC on December 10, 2019)
-
Form of Investor Warrant
(Filed With SEC on December 10, 2019)
-
Form of Pre-Funded Warrant
(Filed With SEC on November 26, 2019)
-
Form of Common Warrant
(Filed With SEC on November 26, 2019)
-
Form of Placement Agent Warrant
(Filed With SEC on November 26, 2019)
-
Form of Securities Purchase Agreement, dated as of November 21, 2019, among Onconova Therapeutics, Inc. and the Purchasers named therein
(Filed With SEC on November 26, 2019)
-
Distribution, License and Supply Agreement, dated as of November 20, 2019, by and between Onconova Therapeutics, Inc. and Knight Therapeutics Inc
(Filed With SEC on November 21, 2019)
-
SECURITIES PURCHASE AGREEMENT
(Filed With SEC on November 14, 2019)
-
Form of Placement Agent Warrant
(Filed With SEC on November 14, 2019)
-
Form of Pre-Funded Warrant
(Filed With SEC on November 14, 2019)
-
Form of Warrant
(Filed With SEC on November 14, 2019)
-
Form of Amendment to Warrant, dated as of September 23, 2019
(Filed With SEC on November 12, 2019)
-
Form of Underwriter Warrant
(Filed With SEC on November 12, 2019)
-
Form of Pre-Funded Warrant
(Filed With SEC on November 12, 2019)
-
Form of Warrant
(Filed With SEC on November 12, 2019)
-
Form of Underwriting Agreement
(Filed With SEC on November 12, 2019)
-
Form of Securities Purchase Agreement, dated as of September 23, 2019, among Onconova Therapeutics, Inc. and the Purchasers named therein
(Filed With SEC on September 25, 2019)
-
Form of Placement Agent Warrant
(Filed With SEC on September 25, 2019)
-
Securities Purchase Agreement, dated as of May 10, 2019, by and between Onconova Therapeutics, Inc. and HanX Biopharmaceuticals, Inc
(Filed With SEC on August 14, 2019)
-
Securities Purchase Agreement, dated as of May 10, 2019, by and between Onconova Therapeutics, Inc. and Abundant New Investments Ltd
(Filed With SEC on August 14, 2019)
-
License and Collaboration Agreement, dated as of May 10, 2019, by and between Onconova Therapeutics, Inc. and HanX Biopharmaceuticals, Inc
(Filed With SEC on August 14, 2019)
-
Sales Agreement, dated May 17, 2019, by and between Onconova Therapeutics, Inc. and Roth Capital Partners, LLC
(Filed With SEC on May 17, 2019)
-
Separation and Release Agreement, effective as of January 15, 2019, by and between Onconova Therapeutics, Inc. and Ramesh Kumar, Ph.D
(Filed With SEC on January 15, 2019)
-
First Amendment to Underwriter Series A Convertible Preferred Stock Purchase Warrant, dated as of September 24, 2018
(Filed With SEC on November 14, 2018)
-
Employment Agreement, effective as of November 5, 2018, by and between the Company and Richard C. Woodman, M.D
(Filed With SEC on November 14, 2018)
-
Amended and Restated Employment Agreement, effective as of June 19, 2018, by and between the Company and Steven M. Fruchtman, M.D
(Filed With SEC on August 14, 2018)
-
Form of Nonqualified Stock Option Award Agreement under the Onconova Therapeutics, Inc. 2018 Omnibus Incentive Compensation Plan
(Filed With SEC on July 30, 2018)
-
Onconova Therapeutics, Inc. 2018 Omnibus Incentive Compensation Plan
(Filed With SEC on June 29, 2018)
-
Securities Purchase Agreement, dated as of March 2, 2018, by and between Onconova Therapeutics, Inc. and Pint Pharma GmbH
(Filed With SEC on May 15, 2018)
-
License, Development and Commercialization Agreement, dated as of March 2, 2018, by and between Onconova Therapeutics, Inc. and Pint International SA
(Filed With SEC on May 15, 2018)
-
Form of Pre-Funded Warrant
(Filed With SEC on April 30, 2018)
-
Form of Lock-Up Waiver Agreement
(Filed With SEC on April 30, 2018)
-
Underwriting Agreement, dated as of April 27, 2018
(Filed With SEC on April 30, 2018)
-
Form of Preferred Stock Warrant
(Filed With SEC on April 30, 2018)
-
Form of Underwriting Agreement
(Filed With SEC on April 26, 2018)
-
Form of Underwriting Agreement
(Filed With SEC on April 25, 2018)
-
Form of Warrant
(Filed With SEC on April 25, 2018)
-
Form of Pre-Funded Warrant
(Filed With SEC on April 25, 2018)
-
Form of Preferred Stock Warrant
(Filed With SEC on February 8, 2018)
-
Form of Pre-Funded Warrant
(Filed With SEC on February 8, 2018)
-
Form of Underwriter Warrant
(Filed With SEC on February 8, 2018)
-
Underwriting Agreement, dated as of February 8, 2018
(Filed With SEC on February 8, 2018)
-
Form of Underwriting Agreement
(Filed With SEC on February 7, 2018)
-
Form of Warrants
(Filed With SEC on February 7, 2018)
-
Form of Pre-Funded Warrants
(Filed With SEC on February 7, 2018)
-
Form of Underwriter Warrant
(Filed With SEC on February 7, 2018)
-
Placement Agency Agreement, dated as of November 9, 2017
(Filed With SEC on November 13, 2017)
-
2,476,190 Shares ONCONOVA THERAPEUTICS, INC. Common Stock UNDERWRITING AGREEMENT
(Filed With SEC on April 24, 2017)
-
www.onconova.com
(Filed With SEC on March 29, 2017)
-
ONCONOVA THERAPEUTICS, INC. Shares of Common Stock (par value $0.01 per share) At Market Issuance Sales Agreement
(Filed With SEC on December 5, 2016)
-
ONCONOVA THERAPEUTICS, INC. WARRANT TO PURCHASE COMMON STOCK
(Filed With SEC on August 15, 2016)
-
[FORM OF WARRANT CERTIFICATE]
(Filed With SEC on August 15, 2016)
-
WARRANT AGREEMENT
(Filed With SEC on August 15, 2016)
-
ONCONOVA THERAPEUTICS, INC. DEALER-MANAGER AGREEMENT July 7, 2016
(Filed With SEC on July 13, 2016)
-
FORM OF WARRANT CERTIFICATE
(Filed With SEC on July 1, 2016)
-
FORM OF WARRANT AGREEMENT
(Filed With SEC on July 1, 2016)
-
ONCONOVA THERAPEUTICS, INC. WARRANT TO PURCHASE COMMON STOCK
(Filed With SEC on July 1, 2016)
-
ONCONOVA THERAPEUTICS, INC. DEALER-MANAGER AGREEMENT , 2016
(Filed With SEC on June 29, 2016)
-
EMPLOYMENT AGREEMENT
(Filed With SEC on February 17, 2016)
-
ONCONOVA THERAPEUTICS, INC. CONTROLLED EQUITY OFFERINGSM TERMINATION OF SALES AGREEMENT
(Filed With SEC on January 6, 2016)
-
COMMON STOCK PURCHASE WARRANT ONCONOVA THERAPEUTICS, INC.
(Filed With SEC on January 6, 2016)
-
SECURITIES PURCHASE AGREEMENT
(Filed With SEC on January 6, 2016)
-
REGISTRATION RIGHTS AGREEMENT
(Filed With SEC on October 8, 2015)
-
PURCHASE AGREEMENT
(Filed With SEC on October 8, 2015)
-
ONCONOVA THERAPEUTICS, INC. CONTROLLED EQUITY OFFERINGSM AMENDMENT NO. 1 TO SALES AGREEMENT
(Filed With SEC on October 5, 2015)
-
AMENDED AND RESTATED EMPLOYMENT AGREEMENT
(Filed With SEC on August 13, 2015)
-
EMPLOYMENT AGREEMENT
(Filed With SEC on July 8, 2015)
-
AMENDED AND RESTATED EMPLOYMENT AGREEMENT
(Filed With SEC on July 8, 2015)
-
EMPLOYMENT AGREEMENT
(Filed With SEC on July 8, 2015)
-
AMENDED AND RESTATED EMPLOYMENT AGREEMENT
(Filed With SEC on July 8, 2015)
-
375 Pheasant Run, Newtown, PA 18940Phone: 267 ###-###-#### Fax: 267 ###-###-#### EMPLOYMENT AGREEMENT
(Filed With SEC on March 30, 2015)
-
Onconova Therapeutics, Inc. Shares (1) Common Stock ($0.01 par value) Underwriting Agreement
(Filed With SEC on July 18, 2013)
-
CONFIDENTIAL MATERIAL OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. DOUBLE ASTERISKS DENOTE SUCH OMISSIONS. DEVELOPMENT AND LICENSE AGREEMENT
(Filed With SEC on July 18, 2013)
-
CONFIDENTIAL
(Filed With SEC on July 18, 2013)